NCT05855096

Brief Summary

The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation. There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The aim of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neurorehabilitation in Turkey.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2023

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 3, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 11, 2023

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
Last Updated

February 14, 2024

Status Verified

February 1, 2024

Enrollment Period

7 days

First QC Date

May 3, 2023

Last Update Submit

February 12, 2024

Conditions

Keywords

neurorehabilitationphysiotherapistperspectives

Outcome Measures

Primary Outcomes (1)

  • Google Form Questionnaire

    It is planned to send the questionnaire prepared via Google Questionnaire to the physiotherapists who accept to participate in the research and meet the inclusion criteria, to the physiotherapists working in the field via social media, the Physiotherapists Association of Turkey and its sub-groups registered members after the necessary permissions are obtained.

    5 minutes

Interventions

Google form questionnaire is performed by responders.

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Physiotherapists who can read and understand Turkish and have at least three years of work experience will be included in the study. It is planned to send the questionnaire prepared via Google Survey to physiotherapists working in the field via non-governmental organizations, social media and association mails. In the questionnaire, it was aimed to question the age, gender, duration of work in the profession, the duration of work in the field of neurorehabilitation, the training received after graduation, the most preferred evaluation and treatment methods for neurological diseases that are mostly encountered in the field.

You may qualify if:

  • Having at least 3 years of patient follow-up experience in the field of neurorehabilitation
  • Men and women of all age groups who are in the active working process physiotherapists
  • Being a volunteer
  • Speaks and understands the Turkish language (for foreign nationals)

You may not qualify if:

  • Respondents who did not or incompletely answered parts of the survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biruni University

Istanbul, Ataşehir, 34752, Turkey (Türkiye)

Location

Related Publications (11)

  • Krug E, Cieza A. Strengthening Health Systems to Provide Rehabilitation Services. Ann Rehabil Med. 2017 Apr;41(2):169-170. doi: 10.5535/arm.2017.41.2.169. Epub 2017 Apr 27. No abstract available.

    PMID: 28503447BACKGROUND
  • Wade DT. What is rehabilitation? An empirical investigation leading to an evidence-based description. Clin Rehabil. 2020 May;34(5):571-583. doi: 10.1177/0269215520905112. Epub 2020 Feb 10.

    PMID: 32037876BACKGROUND
  • Guerra-Vazquez CM, Martinez-Avila M, Guajardo-Flores D, Antunes-Ricardo M. Punicic Acid and Its Role in the Prevention of Neurological Disorders: A Review. Foods. 2022 Jan 18;11(3):252. doi: 10.3390/foods11030252.

    PMID: 35159404BACKGROUND
  • Ona ED, Cano-de la Cuerda R, Sanchez-Herrera P, Balaguer C, Jardon A. A Review of Robotics in Neurorehabilitation: Towards an Automated Process for Upper Limb. J Healthc Eng. 2018 Apr 1;2018:9758939. doi: 10.1155/2018/9758939. eCollection 2018.

    PMID: 29707189BACKGROUND
  • Lexell J, Brogardh C. The use of ICF in the neurorehabilitation process. NeuroRehabilitation. 2015;36(1):5-9. doi: 10.3233/NRE-141184.

    PMID: 25547759BACKGROUND
  • Zis P, Hadjivassiliou M. Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease. Curr Treat Options Neurol. 2019 Feb 26;21(3):10. doi: 10.1007/s11940-019-0552-7.

    PMID: 30806821BACKGROUND
  • Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009 Jan-Mar;24(1):15-45. doi: 10.1515/reveh.2009.24.1.15.

    PMID: 19476290BACKGROUND
  • McDowell FH. Neurorehabilitation. West J Med. 1994 Sep;161(3):323-7. No abstract available.

    PMID: 7975575BACKGROUND
  • Tempest S, Jefferson R. Engaging with clinicians to implement and evaluate the ICF in neurorehabilitation practice. NeuroRehabilitation. 2015;36(1):11-5. doi: 10.3233/NRE-141185.

    PMID: 25547760BACKGROUND
  • Krucoff MO, Rahimpour S, Slutzky MW, Edgerton VR, Turner DA. Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation. Front Neurosci. 2016 Dec 27;10:584. doi: 10.3389/fnins.2016.00584. eCollection 2016.

    PMID: 28082858BACKGROUND
  • van den Broek MD. Why does neurorehabilitation fail? J Head Trauma Rehabil. 2005 Sep-Oct;20(5):464-73. doi: 10.1097/00001199-200509000-00007.

    PMID: 16170254BACKGROUND

Study Officials

  • Guzin Kaya Aytutuldu

    Biruni University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 3, 2023

First Posted

May 11, 2023

Study Start

April 17, 2023

Primary Completion

April 24, 2023

Study Completion

May 30, 2023

Last Updated

February 14, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations